USP30 and Parkinson disease: Therefore, based on multiple studies, USP30 is a key regulatory target of Parkinson’s disease, and its mechanism of action can be summarized as the following points: Dysfunctional pairs of mitochondrial quality control in neurons are the central mechanism of PD pathogenesis, including idiopathic and genetic forms of PD (Borsche et al., 2021).